Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126063432 | 12606343 | 2 | F | 2013 | 20160804 | 20160729 | 20160811 | EXP | CA-AMGEN-CANSP2016097054 | AMGEN | 62.00 | YR | A | M | Y | 0.00000 | 20160811 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126063432 | 12606343 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 126063432 | 12606343 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 15 MG, UNK | 0 | 15 | MG | ||||||||
| 126063432 | 12606343 | 3 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | 400 MG, UNK | 0 | 400 | MG | ||||||||
| 126063432 | 12606343 | 4 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
| 126063432 | 12606343 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126063432 | 12606343 | 6 | C | XELJANZ | TOFACITINIB CITRATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126063432 | 12606343 | 1 | Rheumatoid arthritis |
| 126063432 | 12606343 | 2 | Rheumatoid arthritis |
| 126063432 | 12606343 | 3 | Product used for unknown indication |
| 126063432 | 12606343 | 4 | Product used for unknown indication |
| 126063432 | 12606343 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126063432 | 12606343 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126063432 | 12606343 | Bone erosion | |
| 126063432 | 12606343 | C-reactive protein abnormal | |
| 126063432 | 12606343 | Colitis | |
| 126063432 | 12606343 | Drug effect decreased | |
| 126063432 | 12606343 | Drug ineffective | |
| 126063432 | 12606343 | Drug intolerance | |
| 126063432 | 12606343 | Intestinal polyp | |
| 126063432 | 12606343 | Leukopenia | |
| 126063432 | 12606343 | Memory impairment | |
| 126063432 | 12606343 | Mobility decreased | |
| 126063432 | 12606343 | Nephrolithiasis | |
| 126063432 | 12606343 | Rheumatoid arthritis | |
| 126063432 | 12606343 | Synovitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126063432 | 12606343 | 2 | 20060501 | 0 | ||
| 126063432 | 12606343 | 3 | 20051116 | 0 | ||
| 126063432 | 12606343 | 4 | 201603 | 0 |